Dr. Peter A. Burke JR., D.O.
Nephrology (Kidney) (Nephrology Physician)
- Medicare participating
At a glance
- Medical school
- Philadelphia College of Osteopathic Medicine (2010)
- Years since graduation
- 16
- In the NPI registry since
- 2010
- Medicare patients seen, 2024
- 263
Licensed in Delaware since 2011, according to the Delaware Division of Professional Regulation. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. What an NPI is
Education and training
- 2010Medical school: Philadelphia College of Osteopathic Medicine
- 2010Registered with an NPI (national billing number; not a license date)
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Nephrology Physician primary
DE license C2-0009881 (first issued 2011; active) · MD license H0087200 · PA license OS019350 -
Hospitalist Physician
DE license C2-0009881 (first issued 2011; active) -
Internal Medicine Physician
DE license C2-0009881 (first issued 2011; active)
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Christiana Hospital Newark, DE
- Bayhealth Medical Center, Kent Campus Dover, DE
- Bayhealth Hospital, Sussex Campus Milford, DE
- Union Hospital of Cecil County Elkton, MD
Medical groups
- Christiana Care Health Services Inc (1,483 clinicians)
- Nephrology Associates PA (54 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 263
- Services billed
- 1,363
- Patients’ average age
- 67
| Service | Times | Patients |
|---|---|---|
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 498 | 91 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 272 | 100 |
| Established patient office or other outpatient visit, 40-54 minutes | 224 | 90 |
| Hemodialysis procedure with physician evaluation | 107 | 39 |
| Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | 79 | 65 |
| Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | 38 | 37 |
| Established patient office or other outpatient visit, 30-39 minutes | 20 | 16 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Prednisone Other prescribers in Newark, DE | 177 |
| Cinacalcet Hcl Other prescribers in Newark, DE | 102 |
| Leflunomide Other prescribers in Newark, DE | 100 |
| Amlodipine Besylate Other prescribers in Newark, DE | 99 |
| Methenamine Hippurate Other prescribers in Newark, DE | 85 |
| Valganciclovir Hcl | 67 |
| Losartan Potassium Other prescribers in Newark, DE | 66 |
| Tamsulosin Hcl Other prescribers in Newark, DE | 65 |
| Hydralazine Hcl Other prescribers in Newark, DE | 64 |
| Carvedilol Other prescribers in Newark, DE | 63 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 13 companies reported 27 payments worth $620 in total to this clinician.
| Amgen Inc. | $99.40 |
|---|---|
| Veloxis Pharmaceuticals, Inc. | $87.76 |
| Merck Sharp & Dohme LLC | $85.98 |
| Mallinckrodt Hospital Products Inc. | $60.87 |
| Invivyd Inc | $55.95 |
| Otsuka America Pharmaceutical, Inc. | $51.57 |
| Fresenius USA Marketing, Inc. | $48.13 |
| Calliditas Therapeutics US Inc. | $33.35 |
| Food and Beverage | $620 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.